It is not clear whether the balance amount to be invested in the airline will be in the form of debt-based funds or equity funds by the buyer. In case of the latter, the buyer’s stake will shoot ...
The updated framework under the OBBBA has created new opportunities for the sports and entertainment industries in rural ...
BEIJING, Dec. 30 (Xinhua) -- Chinese Premier Li Qiang has signed a State Council decree issuing a regulation on the implementation of the country's value-added tax (VAT) law, which will take effect on ...
TipRanks on MSN
XTL Biopharmaceuticals takes major impairment on the Social Proxy in first-half 2025 results
XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has provided an announcement. On December 30, 2025, XTL Biopharmaceuticals reported financial ...
Net Power (NPWR) faces high risks from costly technology, weak economics, and looming dilution. Read here for more analysis.
China on Tuesday released the implementing regulations for its law on value-added tax (VAT), detailing operational tax rules ...
Cronos Group operates in a highly competitive industry but has a marked advantage over its peers owing to its vastly superior ...
Zacks Investment Research on MSN
IVZ among top-performing S&P 500 asset managers in 2025: Is it a buy?
The performance of the Invesco IVZ stock has been impressive in 2025. With a 53.5% rally, the company has become one of the ...
YY Group Holding Limited Class A ( (YYGH)) has shared an announcement. On December 26, 2025, YY Group Holding Limited reported unaudited financial results for the six months ended June 30, 2025, ...
It has been an amazing 2025 for the Big Six U.S. banks - no exceptions. Mealor said the universal banks' high levels of capital could more easily be deployed through dividend increases, share buybacks ...
AllAfrica on MSN
Rwanda: The TP Strategy Entrepreneurs Need to Master for Unbreakable Market Leadership
As a Rwandan intellectual property (IP) and business lawyer, in my practice over the years, I have noticed a critical disconnect between entrepreneurial ambition and foundational legal strategy, ...
On December 24, 2025, Sanofi announced that the US Food and Drug Administration issued a complete response letter for its new drug application for tolebrutinib to treat non-relapsing secondary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results